A Large-scale Research for Immunotherapy of Glioblastoma With Autologous Heat Shock Protein gp96
Clinical trial NCT03650257 · UNKNOWN
Trial details
- NCT number
- NCT03650257
- Sponsor
- Cure&Sure Biotech Co., LTD
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-21
- Primary completion
- 2021-08-20
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.